251
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Definition of severity and treatment response in chronic rhinosinusitis with nasal polyps: a Delphi study among French experts

, , ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 1005-1011 | Received 25 Apr 2023, Accepted 14 Jun 2023, Published online: 23 Jun 2023

References

  • Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020 feb 20;58:1‑464.
  • Johansson L, Akerlund A, Holmberg K, et al. Prevalence of nasal polyps in adults: the Skövde population-based study. Ann Otol Rhinol Laryngol. 2003 jul;112(7):625–629.
  • Ahn JC, Kim JW, Lee CH, et al. Prevalence and risk factors of chronic rhinosinusitus, allergic rhinitis, and nasal septal deviation: results of the Korean national health and nutrition survey 2008-2012. JAMA Otolaryngology–Head & Neck Surg. 2016 feb;142(2):162‑7.
  • Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021 mar;11(3):213–739.
  • Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. The Lancet. 2019 nov 2;394(10209):1638–1650.
  • Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 oct;9(10):1141–1153.
  • Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000 oct;32(4):1008–1015. doi: 10.1046/j.1365-2648.2000.t01-1-01567.x
  • Haute autorité de santé française. Elaboration de recommandation de bonne pratique – Recommandations par consensus formalise. 2010.
  • Fokkens WJ, Lund V, Bachert C, et al. EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019 dec;74(12):2312–2319. doi: 10.1111/all.13875
  • Rank MA, Chu DK, Bognanni A, et al. The joint task force on practice parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol. 2022 nov 9;91-6749:01484–1. S00.
  • Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: definitions and management. J Allergy Clin Immunol. 2021 jan;147(1):29–36.
  • Sedaghat AR, Singerman KW, Phillips KM. Discordance of chronic rhinosinusitis disease control between EPOS guidelines and patient perspectives identifies utility of patient-rated control assessment. Rhinology. 2022 dec 1;60:444‑52.
  • Fieux M, Lisan Q, Nevoux J, et al. French health insurance data for chronic rhinosinusitis with nasal polyps between 2011 and 2018: a STROBE-compliant analysis. European Annals Of Otorhinolaryngology, Head And Neck Diseases. 2022 aug 23;S1879-7296(2):00089–8.
  • Scangas GA, Wu AW, Ting JY, et al. Cost utility analysis of dupilumab versus endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps. Laryngoscope. 2021 jan;131(1):E26‑33.
  • Hopkins C, McKenzie JL, Anari S, et al. British rhinological society consensus guidance on the use of biological therapies for chronic rhinosinusitis with nasal polyps. Clin Otolaryngol. 2021 sep;46(5):1037–1043.
  • Fokkens WJ, Lund V, Luong AU, et al. A comparison of international guidelines for rhinosinusitis. J Allergy Clin Immunol Pract. 2022 jun;10(6):1418–1422.
  • Rampi A, Vinciguerra A, Tanzini U, et al. Comparison of guidelines for prescription and follow-up of biologics for chronic rhinosinusitis with nasal polyps. Eur Arch Otorhinolaryngol. 2023 jan;280(1):39–46. doi: 10.1007/s00405-022-07634-x
  • Al-Ahmad M, Alsaleh S, Al-Reefy H, et al. Expert opinion on biological treatment of chronic rhinosinusitis with nasal polyps in the gulf region. JAA. 2022 jan;15:1‑12.
  • Thamboo A, Kilty S, Witterick I, et al. Canadian rhinology working group consensus statement: biologic therapies for chronic rhinosinusitis. J Of Otolaryngol - Head & Neck Surg. 2021 dec;50(1):15.
  • Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis. Nat Rev Dis Primers. 2020 Oct 29;6(1):1–19.
  • Alt JA, Smith TL, Mace JC, et al. Sleep quality and disease severity in patients with chronic rhinosinusitis. Laryngoscope. 2013 Oct;123(10):2364–2370.
  • Bandi S, Stephen E, Bansal K, et al. Understanding the CRSwNP patient as whole. Am J Rhinol Allergy. 2023 Mar;37(2):140–146.
  • Värendh M, Johannisson A, Hrubos-Strøm H, et al. Sleep quality improves with endoscopic sinus surgery in patients with chronic rhinosinusitis and nasal polyposis. Rhinology. 2017 Mar 1;55(1):45–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.